MARIJA ANDRADE: Open Payments
NPI 1811734437 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 42 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $102 · 2025 $803
Food & beverage: $783Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $316 |
| Amgen Inc. | 13 | $179 |
| E.R. Squibb & Sons, L.L.C. | 8 | $136 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| Alnylam Pharmaceuticals Inc. | 1 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
| SCPHARMACEUTICALS INC. | 1 | $16 |
Products named: Ozempic, REPATHA, Wegovy, ELIQUIS, LEQVIO, ONPATTRO, CAMZYOS, Kerendia.
Industry payments across TX — which companies pay providers there.
